James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

3 Healthcare Acquisitions Google Should Consider

The best way for Google to make an even bigger splash in healthcare is through smart acquisitions like these 3 companies.

5 Value Stocks to Buy Now

Investors looking for some new stocks to buy may want to consider these value stocks first.

Merck’s Keytruda Win Signals a Big Shift for Big Pharma

MRK per-share profits and revenue are poised to rebound now that its research and development efforts are getting traction.

Best $5 Stocks to Buy Now

Traders looking for new stocks to buy should start the search with stocks under $5 per share. Here are 5 of the best stocks in that price range.

Atlantic City Closings a Grave Omen for Casino Stocks

Casino stocks have been hit-and-miss for a while, but recent abdications suggest we're entering a rough patch.